F. Boxall

The myelotoxicity of carboplatin is influenced by the time of its administration

D. Kerr, S. Kaye, D. Newell, 1990, Hematological oncology.

Plasma free platinum pharmacokinetics in patients treated with high dose carboplatin.

M. Gore, I. Smith, Z. Siddik, 1987, European journal of cancer & clinical oncology.

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

E Wiltshaw, A H Calvert, M. Gore, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.